NLRC5 and melanoma: Then, we performed Kaplan-Meier analysis of NLRC5 expression in melanoma patients and found that low expression of NLRC5 was significantly associated with poor OS (overall survival) (log-rank p < 0.0001, Figure 2A), DSS (disease specific survival) (log-rank p < 0.0001, Figure 2B), and PFI (progression-free interval) (log-rank p = 0.002, Figure 2C) in TCGA SKCM.